| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |